Sands Frank M. insider trades
Sands Frank M. has filed 2 Form 4s with the SEC that we hold, for Acumen Pharmaceuticals, Inc. (ABOS) (10% owner) and Inhibikase Therapeutics, Inc. (IKT) (10% owner). Across all of them we count 2 purchases worth $9.7M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($3.0M) and 0 sales ($0). The largest single trade was a purchase of 450,000 shares of Acumen Pharmaceuticals, Inc. worth $6.7M, dated 2021-07-06. The first filing on our record is dated 2021-07-08 and the latest 2025-11-24.
Acumen Pharmaceuticals, Inc. (ABOS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-06 | P, purchase reported on Form 4 | 450,000 | $6.7M | 2021-07-08 |
Inhibikase Therapeutics, Inc. (IKT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-21 | P, purchase reported on Form 4 | 2,068,965 | $3.0M | 2025-11-24 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1870494) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms